BIOREGENX, INC. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f4f507ae-a30a-43d8-9cab-cad13cd6ba01/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.5M | 2025-01-01 – 2025-12-31 | evidence 0001683168-26-002975 |
| FY 2024 | $-23.1M | 2024-01-01 – 2024-12-31 | evidence 0001683168-25-002614 |
| FY 2023 | $-3.6M | 2023-01-01 – 2023-12-31 | evidence 0001683168-25-002614 |
| FY 2022 | $-78.3k | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-002125 |
| FY 2021 | $-96.9k | 2021-01-01 – 2021-12-31 | evidence 0001683168-23-002125 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).